المؤلفون: Fredlund, Hans

مصطلحات موضوعية: Meningitis, meningococcal: immunology, Neisseria meningititis: immunology, Neutrophils: immunology, Neisseria meningitidis

المؤلفون: Hannah Christensen, Caroline Trotter, Hajime Kamiya, Sergey Sidorenko, Josefina Carlos, Dominique A. Caugant, Roberto Debbag, Ray Borrow, Marco Aurélio Palazzi Sáfadi, Muhamed-Kheir Taha, Chris Head, Philippe De Wals, Jamie Findlow, Daphne Holt, Anne von Gottberg, Gabriela Echániz-Aviles, Pedro Alarcón, Samir K. Saha, Julio A. Vázquez Moreno

المساهمون: Manchester Royal Infirmary, University of Manchester [Manchester], Instituto de Salud Pública de Chile (ISP), University of the East – Ramon Magsaysay Memorial Medical Center [Philippines], Norwegian Institute of Public Health [Oslo] (NIPH), University of the West of England [Bristol] (UWE Bristol), Malvinas Children's Hospital [Buenos Aires], Université Laval [Québec] (ULaval), National Institute of Public Health = Instituto Nacional de Salud Pública [Cuernavaca, Mexique] (INSP), Meningitis Research Foundation [Bristol], Confederation of Meningitis Organisations [Bristol] (CoMO), National Institute of Infectious Diseases [Tokyo], Dhaka Shishu Hospital [Bangladesh], Scientific Research Institute of Children's Infections [Saint-Petersburg, Russia], Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], University of Cambridge [UK] (CAM), Institute of Health Carlos III, National Institute for Communicable Diseases [Johannesburg] (NICD), FCM Santa Casa de São Paulo School of Medical Sciences [São Paulo], The GMI is funded by an educational grant from Sanofi Pasteur, however, the group is not led in any way by the company. GMI members determine meeting agenda items and lead the discussions and outputs. Medical writing support was provided by Shelley Lindley, PhD, of PAREXEL, which was funded by Sanofi Pasteur. R Borrow and J Findlow perform contract research on behalf of Public Health England for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur, and Sanofi Pasteur MSD. DA Caugant has performed in the past contract research on behalf of the Norwegian Institute of Public Health for Novartis, Pfizer, and Sanofi Pasteur. H Christensen has received an honorarium from Sanofi Pasteur for running a GMI modeling workshop paid to her employer. Furthermore, H Christensen is supported by the National Institute for Health Research [PDF-2012-05-245] and is a member of the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol, UK. S Sidorenko has received grants from Pfizer, outside the submitted work. P De Wals has received research grants and reimbursements of travel expenses from vaccine manufacturers including GlaxoSmithKline, Novartis, Sanofi Pasteur, and Pfizer, as well as from governmental agencies including the Quebec Ministry of Health and Social Services, Health Canada, and the Public Health Agency of Canada. J Carlos has received research grant support from GlaxoSmithKline, Novartis, and Sanofi Pasteur, however, no conflict of interest relevant to this manuscript is reported. M-K Taha performs contract research on behalf of Institut Pasteur for GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. C Trotter received a consulting payment from GlaxoSmithKline in 2013 for critical review of a health economic model of meningococcal vaccines and an honorarium from Sanofi Pasteur in 2015 for running a GMI modeling workshop. JA Vázquez Moreno performed contract research on behalf of Institute of Health Carlos III for Baxter Biosciences, GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. A von Gottberg received research funding from Pfizer. MAP Sáfadi has received grants to support research projects from GlaxoSmithKline, Novartis, Pfizer, and Sanofi Pasteur. This work is produced by the authors under the terms of the research training fellowships issued by the NIHR. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, NIHR, the Department of Health, or Public Health England. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed., Global Meningococcal Initiative, Institut Pasteur [Paris] (IP)

المصدر: Expert Review of Vaccines
Expert Review of Vaccines, Expert Reviews (formerly Future Drugs), 2017, 16 (4), pp.313-328. ⟨10.1080/14760584.2017.1258308⟩
Borrow, R, Alarcon, P, Carlos, J, Caugant, D, Christensen, H, Debbag, R, De Wals, P, Echániz-Aviles, G, Findlow, J, Head, C, Holt, D, Kamiya, H, Saha, S, Sidorenko, S, Taha, M-K, Trotter, C, Vázquez Moreno, J & Von Gottberg, A 2016, ' The global meningococcal initiative : global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection ', Expert Review of Vaccines, vol. 16, no. 4, pp. 313-328 . https://doi.org/10.1080/14760584.2017.1258308
Expert Review of Vaccines, 2017, 16 (4), pp.313-328. ⟨10.1080/14760584.2017.1258308⟩

مصطلحات موضوعية: 0301 basic medicine, Epidemiology, MESH: Meningococcal Vaccines/immunology, MESH: Global Health, Neisseria meningitidis, medicine.disease_cause, Global Health, MESH: Immunization Programs, Disease Outbreaks, MESH: Neisseria meningitidis/immunology, MESH: Meningococcal Infections/prevention & control, MESH: Meningococcal Infections/epidemiology, 0302 clinical medicine, prevention, MESH: Meningococcal Vaccines/therapeutic use, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Discovery, Global health, 030212 general & internal medicine, MESH: Incidence, Global Meningococcal Initiative, MESH: Vaccines, Conjugate/immunology, Incidence, MESH: Meningitis, Meningococcal/immunology, MESH: Disease Outbreaks/prevention & control, 3. Good health, Vaccination, outbreaks, surveillance, Molecular Medicine, African meningitis belt, serogroups, 030106 microbiology, Immunology, Meningococcal Vaccines, Meningococcal vaccine, MESH: Meningitis, Meningococcal/epidemiology, Meningitis, Meningococcal, Meningococcal disease, 03 medical and health sciences, Environmental health, MESH: Meningitis, Meningococcal/prevention & control, Epidemiology, Global Meningococcal Initiative, meningococcal disease, MenW, Neisseria meningitidis, outbreaks, prevention, serogroups, surveillance, vaccination, medicine, Humans, MESH: Vaccines, Conjugate/therapeutic use, MenW, Pharmacology, meningococcal disease, Vaccines, Conjugate, MESH: Humans, business.industry, Immunization Programs, Outbreak, medicine.disease, vaccination, Meningococcal Infections, Carriage, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Neisseria meningitidis/classification, business, MESH: Meningococcal Infections/immunology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::947fbc0febe4f30dc29854d4fd1140b1
https://hal-pasteur.archives-ouvertes.fr/pasteur-02013240

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.